Apellis Pharmaceuticals, Inc. (APLS)

25.22 +0.05 (+0.20%) USD  |  NASDAQ  |  Dec 30, 14:46
More

Apellis Pharmaceuticals EV to Revenues

EV to Revenues Chart

View EV to Revenues for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. --

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to EBITDA Upgrade
EV to EBIT Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade